Sigenics

About:

Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon

Twitter/X: sigenics

Top Investors: National Institutes of Health

Description:

Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon. In the beginning, Sigenics’ goal was to develop silicon devices to aid in biomedical research. We have grown to become a designer and supplier of “private-label” silicon chips for Original Equipment Manufacturers (OEM) of electronic equipment in multiple markets including: medical, aerospace, industrial, and military.

Total Funding Amount:

$1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2000-01-01

Contact Email:

sales(AT)sigenics.com

Founders:

Douglas Kerns, Glenn A. DeMichele, Philip R. Troyk

Number of Employees:

11-50

Last Funding Date:

2017-05-03

IPO Status:

Private

Industries: